Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.280
-0.080 (-5.88%)
At close: Feb 21, 2025, 4:00 PM
1.288
+0.008 (0.64%)
After-hours: Feb 21, 2025, 6:51 PM EST
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $76.12 million as of February 21, 2025. Its market cap has decreased by -55.38% in one year.
Market Cap
76.12M
Enterprise Value
-48.16M
1-Year Change
-55.38%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $76.12M, a decrease of -85.47%. That is a compound annual growth rate of -43.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 76.12M | -17.95% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |